DCN Diagnostics

Private

Carlsbad, CaliforniaHealthcare & Life Scienceshttps://dcndx.com/

Last Round

Growth Equity

Nov 3, 2020

Company Overview

DCN Diagnostics is a biotechnology company that provides contract development, manufacturing, and clinical research services for in vitro diagnostic (IVD) products.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

lateral flow assayCDMOCROin vitro diagnosticsIVDdiagnostic test developmentpoint-of-care testingPOCTregulatory consultingclinical validationassay manufacturingdiagnostic readermedical device consultingrapid diagnostic testbiotech outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DCN Diagnostics Comps

Public and private peers based on sector, stage, and business model.

DCN Diagnostics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DCN Diagnostics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Growth Equity	Nov 3, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Charlie Mamrak

CEO, Board Director

Executive Team

Angela Rapattoni

Chief Financial Officer

Executive Team

Patrick Vaughan

Chief Operating Officer

Executive Team

DCN Diagnostics Investors

Notable investors and investment history

DCN Diagnostics investors
Investor	Rounds
Martis Capital Management	Growth Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Nov 3, 2020
Raised Growth Equity round led by Martis Capital Management.

View all signals

DCN Diagnostics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DCN Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DCN Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California

Employee Range85

Year Founded2002

Last FundingNov 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.